Evaluation of the protective effect of a prime-boost strategy with plasmid DNA followed by recombinant adenovirus expressing BmAMA1 as vaccines against Babesia microti infection in hamster

被引:0
|
作者
Guanbo Wang
Longzheng Yu
Artemis Efstratiou
Paul Franck Adjou Moumouni
Mingming Liu
Huanping Guo
Yang Gao
Shinuo Cao
Mo Zhou
Jixu Li
Aaron Edmond Ringo
Xuenan Xuan
机构
[1] Obihiro University of Agriculture and Veterinary Medicine,National Research Center for Protozoan Diseases
[2] Yanbian University,Department of Veterinary Medicine
[3] Harbin Veterinary Research Institute,State Key Laboratory of Veterinary Biotechnology
[4] Chinese Academy of Agricultural Sciences,undefined
来源
Acta Parasitologica | 2018年 / 63卷
关键词
DNA vaccine; Adenovirus; Heterologous prime-boost; BmAMA1;
D O I
暂无
中图分类号
学科分类号
摘要
In the present study, we have investigated the protective effect of a heterologous prime-boost strategy with priming plasmid DNA followed by recombinant adenovirus, both expressing BmAMA1, against Babesia microti infection. Four groups consisting of 3 hamsters per group were immunized with pBmAMA1/Ad5BmAMA1, pNull/Ad5BmAMA1, pBmAMA1/Ad5Null and pNull/Ad5Null, followed by challenge infection with B. microti. Our results showed that hamsters immunized with plasmid and adenovirus expressing BmAMA1 developed a robust IgG and IgG2a antibody response against BmAMA1, suggesting the DNA vaccine or viral vector vaccine tend to induce a Th1-biased response. Compared to the control hamsters, the hamsters vaccinated either with the prime-boost strategy or one of the two “vaccines” exhibited no significant protection against B. microti challenge. Although a slight difference in terms of parasitemia and hematocrit values at days 14–16 post challenge infection was observed, no other statistical difference was detected. Our results indicate that the prime-boost vaccination strategy of injection of plasmid and adenovirus expressing BmAMA1 is not efficient in protecting against B. microti infection.
引用
收藏
页码:368 / 374
页数:6
相关论文
共 23 条
  • [1] Evaluation of the protective effect of a prime-boost strategy with plasmid DNA followed by recombinant adenovirus expressing BmAMA1 as vaccines against Babesia microti infection in hamster
    Wang, Guanbo
    Yu, Longzheng
    Efstratiou, Artemis
    Moumouni, Paul Franck Adjou
    Liu, Mingming
    Guo, Huanping
    Gao, Yang
    Cao, Shinuo
    Zhou, Mo
    Li, Jixu
    Ringo, Aaron Edmond
    Xuan, Xuenan
    ACTA PARASITOLOGICA, 2018, 63 (02) : 368 - 374
  • [2] Protective effect of a prime-boost strategy with plasmid DNA followed by recombinant adenovirus expressing TgAMA1 as vaccines against Toxoplasma gondii infection in mice
    Yu, Longzheng
    Yamagishi, Junya
    Zhang, Shoufa
    Jin, Chunmei
    Aboge, Gabriel Oluga
    Zhang, Houshuang
    Zhang, Guohong
    Tanaka, Tetsuya
    Fujisaki, Kozo
    Nishikawa, Yoshifumi
    Xuan, Xuenan
    PARASITOLOGY INTERNATIONAL, 2012, 61 (03) : 481 - 486
  • [3] Prime-boost immunization with DNA followed by a recombinant vaccinia virus expressing P50 induced protective immunity against Babesia gibsoni infection in dogs
    Fukumoto, Shinya
    Tamaki, Yoh
    Okamura, Masashi
    Bannai, Hiroshi
    Yokoyama, Natsuko
    Suzuki, Tomoko
    Igarashi, Ikuo
    Suzuki, Hiroshi
    Xuan, Xuenan
    VACCINE, 2007, 25 (07) : 1334 - 1341
  • [4] Prime-boost vaccination with plasmid DNA followed by recombinant vaccinia virus expressing BgGARP induced a partial protective immunity to inhibit Babesia gibsoni proliferation in dogs
    Shinuo Cao
    Ahmed Abdelmoniem Mousa
    Gabriel Oluga Aboge
    Ketsarin Kamyingkird
    Mo Zhou
    Paul Franck Adjou Moumouni
    Mohamad Alaa Terkawi
    Tatsunori Masatani
    Yoshifumi Nishikawa
    Hiroshi Suzuki
    Shinya Fukumoto
    Xuenan Xuan
    Acta Parasitologica, 2013, 58 : 619 - 623
  • [5] Prime-boost vaccination with plasmid DNA followed by recombinant vaccinia virus expressing BgGARP induced a partial protective immunity to inhibit Babesia gibsoni proliferation in dogs
    Cao, Shinuo
    Mousa, Ahmed Abdelmoniem
    Aboge, Gabriel Oluga
    Kamyingkird, Ketsarin
    Zhou, Mo
    Moumouni, Paul Franck Adjou
    Terkawi, Mohamad Alaa
    Masatani, Tatsunori
    Nishikawa, Yoshifumi
    Suzuki, Hiroshi
    Fukumoto, Shinya
    Xuan, Xuenan
    ACTA PARASITOLOGICA, 2013, 58 (04) : 619 - 623
  • [6] Immunogenicity and protective efficacy of heterologous prime-boost regimens with mycobacterial vaccines and recombinant adenovirus- and poxvirus-vectored vaccines against murine tuberculosis
    You, Qingrui
    Wu, Yongge
    Wu, Yang
    Wei, Wei
    Wang, Changyong
    Jiang, Dehua
    Yu, Xianghui
    Zhang, Xizhen
    Wang, Yong
    Tang, Zhijiao
    Jiang, Chunlai
    Kong, Wei
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (11) : E816 - E825
  • [7] A prime-boost vaccination strategy using naked DNA followed by recombinant porcine adenovirus protects pigs from classical swine fever
    Hammond, JM
    Jansen, ES
    Morrissy, CJ
    Goff, WV
    Meehan, GC
    Williamson, MM
    Lenghaus, C
    Sproat, KW
    Andrew, ME
    Coupar, BEH
    Johnson, MA
    VETERINARY MICROBIOLOGY, 2001, 80 (02) : 101 - 119
  • [8] Protective Effect of a Prime-Boost Strategy with the Ts87 Vaccine against Trichinella spiralis Infection in Mice
    Gu, Yuan
    Zhan, Bin
    Yang, Yaping
    Yang, Xiaodi
    Zhao, Xi
    Wang, Lei
    Yang, Jing
    Bi, Kuo
    Wang, Yunyun
    Zhu, Xinping
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [9] Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV
    K-Q Xin
    N Jounai
    K Someya
    K Honma
    H Mizuguchi
    S Naganawa
    K Kitamura
    T Hayakawa
    S Saha
    F Takeshita
    K Okuda
    M Honda
    D M Klinman
    K Okuda
    Gene Therapy, 2005, 12 : 1769 - 1777
  • [10] Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV
    Xin, KQ
    Jounai, N
    Someya, K
    Honma, K
    Mizuguchi, H
    Naganawa, S
    Kitamura, K
    Hayakawa, T
    Saha, S
    Takeshita, F
    Okuda, K
    Honda, M
    Klinman, DM
    Okuda, K
    GENE THERAPY, 2005, 12 (24) : 1769 - 1777